Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,DLL1,Delta-like protein 1,Inverse variance weighted,13,1.49 [0.77-2.86],0.237755255532794
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,0.79 [0.40-1.53],0.477987309512852
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.41 [0.75-2.68],0.288572691520305
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,2.82 [0.41-19.47],0.293685237249399
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.97 [0.68-1.38],0.861883082139177
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REN,Renin,Inverse variance weighted,12,1.31 [0.80-2.16],0.282796467289438
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.90 [0.47-1.73],0.747632525034404
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.18 [0.74-1.87],0.480630586826599
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CST3,Cystatin-C,Inverse variance weighted,13,1.59 [0.92-2.75],0.0977639073178531
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.96 [0.40-2.29],0.924493504431156
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.41 [1.12-1.78],0.003890253336309
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.80 [0.04-15.28],0.882258611402431
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.32 [0.65-2.69],0.436829278009455
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.83 [0.64-1.08],0.173940021282275
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.00 [0.08-12.75],0.997344779645072
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.91 [0.61-1.34],0.632274902531527
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.01 [0.80-1.27],0.948468360242759
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,2.36 [0.62-8.94],0.206228969148818
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,1.36 [0.77-2.38],0.286602074473779
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.77 [0.32-1.83],0.550462371969877
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.40 [0.16-1.01],0.0516459366917497
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FAM3C,Protein FAM3C,Inverse variance weighted,5,0.84 [0.09-8.17],0.880246109954148
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LGALS4,Galectin-4,Inverse variance weighted,19,0.90 [0.63-1.29],0.577897780891026
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,0.86 [0.53-1.40],0.533579332575851
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.34 [0.28-6.31],0.71279127689429
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.05 [0.77-1.45],0.748523653089943
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SHISA5,Protein shisa-5,Inverse variance weighted,16,0.48 [0.13-1.69],0.250570367292373
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NECTIN2,Nectin-2,Inverse variance weighted,8,1.00 [0.65-1.55],0.992384222772936
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD302,CD302 antigen,Inverse variance weighted,17,1.42 [0.86-2.34],0.172237716978371
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AGRN,Agrin,Inverse variance weighted,31,0.79 [0.53-1.18],0.251126246740646
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.65 [0.30-1.37],0.255679884730684
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.18 [0.15-9.07],0.872200331259898
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,KLK4,Kallikrein-4,Inverse variance weighted,20,0.97 [0.67-1.41],0.860990964059302
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.63 [0.41-6.46],0.483580334437911
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,0.94 [0.56-1.60],0.830959599548546
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.09 [0.50-2.34],0.834000160091443
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PGF,Placenta growth factor,Inverse variance weighted,8,0.75 [0.24-2.33],0.614071025827093
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NECTIN4,Nectin-4,Inverse variance weighted,12,0.89 [0.57-1.38],0.591354306325453
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.90 [0.15-5.31],0.911055430790354
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.34 [0.11-1.08],0.0664883351595419
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.52 [0.30-7.57],0.611697486589649
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.51 [0.21-1.24],0.135958625384652
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.04 [0.81-1.33],0.767019599382948
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.58 [0.20-1.68],0.318313153935279
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.44 [0.13-1.50],0.187148444582828
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,COLEC12,Collectin-12,Inverse variance weighted,13,0.69 [0.38-1.26],0.225156208505463
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.49 [1.06-2.09],0.0216615652552188
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.90 [0.26-3.08],0.867799333512662
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.84 [0.34-2.05],0.695581048277397
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.79 [0.54-1.14],0.208969176980982
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,1.45 [0.79-2.68],0.233273408201861
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,OGN,Mimecan,Inverse variance weighted,37,0.78 [0.57-1.07],0.120268427547871
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,1.02 [0.29-3.63],0.970272044054656
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.56 [0.83-2.92],0.168823525563494
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPON2,Spondin-2,Inverse variance weighted,8,0.88 [0.50-1.57],0.673684419111167
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPON1,Spondin-1,Inverse variance weighted,25,0.97 [0.63-1.49],0.874333256711405
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,0.95 [0.71-1.28],0.742839788481253
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,3,1.66 [0.28-9.79],0.577962984596229
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.77 [0.87-3.61],0.113945962336028
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.17 [0.87-1.58],0.288181535602548
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.28 [0.08-0.92],0.0368720442436243
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.43 [0.80-2.55],0.22638529288285
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PALM2,Paralemmin-2,Inverse variance weighted,9,1.03 [0.55-1.92],0.921715271450637
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.99 [0.57-1.70],0.960757943931843
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,0.78 [0.55-1.10],0.161046213395885
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.61 [0.13-2.86],0.527356848216326
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.63 [0.34-1.17],0.142086430104878
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.93 [0.41-2.14],0.871851323144664
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.95 [1.04-3.67],0.0380940607415293
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.07 [0.60-1.91],0.816338612637484
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.03 [0.54-1.94],0.930621893886641
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.25 [0.80-1.96],0.324194403171174
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.86 [0.22-3.43],0.831267083235989
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.96 [0.63-1.46],0.840490918988794
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.53 [0.81-2.89],0.185866355012544
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,3.61 [0.11-113.97],0.466501536389818
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,KLK11,Kallikrein-11,Inverse variance weighted,19,1.11 [0.76-1.63],0.591868144184839
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.33 [0.12-0.95],0.0405766581890249
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.87 [0.57-1.33],0.527200119089923
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.57 [0.38-0.85],0.0062274700059738
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD59,CD59 glycoprotein,Inverse variance weighted,8,0.86 [0.48-1.54],0.607019831428788
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,MMP7,Matrilysin,Inverse variance weighted,15,0.70 [0.47-1.03],0.0719506749887257
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.02 [0.72-1.44],0.906007842640959
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,3.67 [0.87-15.60],0.0778171619784796
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GUCA2A,Guanylin,Inverse variance weighted,16,1.22 [0.69-2.17],0.492628433674648
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.62 [0.41-6.44],0.496526529291761
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.52 [0.22-1.22],0.131666016769414
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.99 [0.65-1.50],0.962693817307149
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.42 [0.72-2.81],0.310751590227654
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.83 [1.08-3.13],0.0260032060720081
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LAYN,Layilin,Inverse variance weighted,23,1.23 [0.81-1.88],0.328404632478484
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,0.61 [0.31-1.22],0.165349338712727
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.31 [0.31-5.53],0.716817366577911
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.86 [0.40-1.88],0.708291145027538
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,2.46 [0.85-7.11],0.0956598183869012
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.87 [0.87-4.02],0.106814640532396
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.04 [0.66-1.66],0.853633105414713
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.57 [0.25-1.27],0.168612886346539
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD27,CD27 antigen,Inverse variance weighted,18,1.01 [0.66-1.54],0.97945119866003
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.95 [0.35-2.63],0.92849624715172
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,1.09 [0.72-1.65],0.694548617343042
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AMBP,Protein AMBP,Inverse variance weighted,5,0.64 [0.25-1.64],0.356060874514604
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AREG,Amphiregulin,Inverse variance weighted,7,1.28 [0.56-2.95],0.560883959530479
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.47 [0.55-3.92],0.44632125713696
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.12 [0.71-1.76],0.619984763783071
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,2.05 [0.91-4.62],0.0821986615326711
